KIR4.1 Antibodies

Santa Cruz Biotechnology features a diverse variety of KIR4.1 monoclonal antibodies for investigating the role of KIR4.1 protein. KIR4.1 Antibodies are compatible with multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).KIR4.1, also known as potassium inwardly-rectifying channel, is crucial for maintaining potassium ion homeostasis in cells, playing a significant role in neuronal excitability and muscle contraction. Its proper functioning is essential for various physiological processes, and dysregulation of KIR4.1 has been implicated in several neurological disorders and cardiac conditions. Understanding the expression and function of KIR4.1 is vital for advancing research in these areas. KIR4.1 monoclonal antibodies enable researchers to explore cellular mechanisms and pathways involved in potassium regulation. Investigating KIR4.1 expression patterns helps reveal its distribution across different tissue types and cellular compartments. Studying KIR4.1 localization provides insights into ion channel clustering and membrane organization. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of KIR4.1's role in health and disease.